West Pharmaceutical Services PE Ratio 2010-2024 | WST

Current and historical p/e ratio for West Pharmaceutical Services (WST) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. West Pharmaceutical Services PE ratio as of November 22, 2024 is 46.83.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

West Pharmaceutical Services PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-11-21 320.88 47.61
2024-09-30 299.98 $6.74 44.51
2024-06-30 328.97 $7.03 46.80
2024-03-31 395.01 $7.58 52.11
2023-12-31 351.31 $7.88 44.58
2023-09-30 374.35 $7.41 50.52
2023-06-30 381.40 $6.86 55.60
2023-03-31 345.31 $7.28 47.43
2022-12-31 234.39 $7.72 30.36
2022-09-30 244.87 $8.29 29.54
2022-06-30 300.70 $9.01 33.37
2022-03-31 408.25 $9.00 45.36
2021-12-31 465.98 $8.70 53.56
2021-09-30 421.61 $8.06 52.31
2021-06-30 356.46 $6.84 52.11
2021-03-31 279.56 $5.58 50.10
2020-12-31 280.92 $4.58 61.34
2020-09-30 272.42 $4.13 65.96
2020-06-30 224.98 $3.79 59.36
2020-03-31 150.64 $3.46 43.54
2019-12-31 148.59 $3.20 46.43
2019-09-30 140.01 $3.05 45.91
2019-06-30 123.41 $3.03 40.73
2019-03-31 108.52 $2.90 37.42
2018-12-31 96.40 $2.75 35.05
2018-09-30 121.26 $2.06 58.86
2018-06-30 97.37 $2.00 48.69
2018-03-31 86.45 $1.76 49.12
2017-12-31 96.48 $1.99 48.48
2017-09-30 93.98 $2.51 37.44
2017-06-30 92.15 $2.34 39.38
2017-03-31 79.44 $2.43 32.69
2016-12-31 82.45 $1.92 42.94
2016-09-30 72.28 $1.85 39.07
2016-06-30 73.50 $1.37 53.65
2016-03-31 67.04 $1.15 58.29
2015-12-31 58.11 $1.30 44.70
2015-09-30 52.11 $1.28 40.71
2015-06-30 55.83 $1.69 33.03
2015-03-31 57.76 $1.83 31.56
2014-12-31 50.97 $1.76 28.96
2014-09-30 42.74 $1.66 25.75
2014-06-30 40.18 $1.60 25.11
2014-03-31 41.86 $1.51 27.73
2013-12-31 46.53 $1.58 29.45
2013-09-30 38.95 $1.55 25.13
2013-06-30 33.16 $1.40 23.77
2013-03-31 30.56 $1.19 25.68
2012-12-31 25.68 $1.15 22.42
2012-09-30 24.80 $1.12 22.24
2012-06-30 23.51 $1.15 20.53
2012-03-31 19.72 $1.21 16.36
2011-12-31 17.51 $1.08 16.21
2011-09-30 17.04 $0.90 18.93
2011-06-30 20.02 $0.91 22.00
2011-03-31 20.40 $0.94 21.82
2010-12-31 18.70 $0.94 19.89
2010-09-30 15.50 $1.15 13.54
2010-06-30 16.41 $1.14 14.39
2010-03-31 18.79 $1.12 16.86
2009-12-31 17.49 $1.06 16.50
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.928B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.108B 21.59
Becton Dickinson (BDX) United States $64.745B 17.02
Cardinal Health (CAH) United States $29.487B 15.99
Cooper (COO) United States $20.075B 28.58
Labcorp (LH) United States $20.046B 16.62
Align Technology (ALGN) United States $16.863B 32.27
Henry Schein (HSIC) United States $9.361B 17.83
Merit Medical Systems (MMSI) United States $6.139B 31.35
DENTSPLY SIRONA (XRAY) United States $3.731B 10.15
CONMED (CNMD) United States $2.314B 19.31
Patterson (PDCO) United States $1.803B 9.52
STAAR Surgical (STAA) United States $1.315B 48.51
Lifevantage (LFVN) United States $0.178B 23.67
Pro-Dex (PDEX) United States $0.152B 30.36